Kite Pharma Competitors and Similar CompaniesClear all

Amgen's competitors and similar companies include Novartis and Juno Therapeutics.

	Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.	Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
Founding Date	Founding Date 1980	Founding Date 1996	Founding Date 2013
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development genetics oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinics pharma platform
Locations	Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more	Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US
Employees	Employees 25,200	Employees 75,883	Employees 1091% decrease
Financial
Revenue (est.)	Revenue (est.) $36.8b (FY, 2025)	Revenue (est.) $56.7b (FY, 2025)	Revenue (est.) $111.9m (FY, 2017)
Cost of goods	Cost of goods $12b (FY, 2025)	Cost of goods $8.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $24.7b (FY, 2025)	Gross profit $49.8b (FY, 2025)	Gross profit N/A
Net income	Net income $7.7b (FY, 2025)	Net income $14b (FY, 2025)	Net income ($437.1m) (FY, 2017)
Operating ⚠
Patents (US)	Patents (US) 31 (FY, 2020)	Patents (US) N/A	Patents (US) 72 (FY, 2016)
Phase III Trials Products	Phase III Trials Products 11 (FY, 2020)	Phase III Trials Products 44 (FY, 2022)	Phase III Trials Products N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 6.5m	Total funding raised $ 310m